NCT07075445View on ClinicalTrials.gov

Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions

Long QT Syndrome Type 3Long QT Syndrome 2

Trial Locations (1)

27858

East Carolina University, Greenville

All Listed Sponsors

lead

Thryv Therapeutics, Inc.

INDUSTRY